These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2404871)

  • 1. Characterization of anti-core glycolipid monoclonal antibodies with chemically defined lipopolysaccharides.
    de Jongh-Leuvenink J; Schellekens J; Verhoef J
    Infect Immun; 1990 Feb; 58(2):421-6. PubMed ID: 2404871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.
    Aydintug MK; Inzana TJ; Letonja T; Davis WC; Corbeil LB
    J Infect Dis; 1989 Nov; 160(5):846-57. PubMed ID: 2681436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
    Nys M; Cloes JM; Demonty J; Joassin L
    J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity and cross-reactivity of monoclonal antibodies reactive with the core and lipid A regions of bacterial lipopolysaccharide.
    Pollack M; Chia JK; Koles NL; Miller M; Guelde G
    J Infect Dis; 1989 Feb; 159(2):168-88. PubMed ID: 2915151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides.
    Di Padova FE; Brade H; Barclay GR; Poxton IR; Liehl E; Schuetze E; Kocher HP; Ramsay G; Schreier MH; McClelland DB
    Infect Immun; 1993 Sep; 61(9):3863-72. PubMed ID: 8359907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different origins.
    Appelmelk BJ; Maaskant JJ; Verweij-van Vught AM; van der Meer NM; Thijs BG; MacLaren DM
    J Gen Microbiol; 1993 Nov; 139(11):2641-7. PubMed ID: 7506295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of monoclonal antibodies to core glycolipid to bind intact smooth strains of Escherichia coli.
    Gigliotti F; Shenep JL
    J Infect Dis; 1985 Jun; 151(6):1005-11. PubMed ID: 2582064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological relationships between Escherichia coli and Salmonella smooth- and rough-mutant lipopolysaccharides as revealed by enzyme-linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies.
    Barclay GR; Scott BB
    Infect Immun; 1987 Nov; 55(11):2706-14. PubMed ID: 3312008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical specificity of human antibodies to lipopolysaccharide from the J5 rough mutant of Escherichia coli O111:B4.
    Schwartzer TA; Alcid DV; Numsuwan V; Gocke DJ
    J Infect Dis; 1989 Jan; 159(1):35-42. PubMed ID: 2462603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5.
    Baumgartner JD; Heumann D; Calandra T; Glauser MP
    J Infect Dis; 1991 Apr; 163(4):769-72. PubMed ID: 2010630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactive murine monoclonal antibodies directed against the core/lipid A region of endotoxin inhibit production of tumor necrosis factor.
    Mayoral JL; Dunn DL
    J Surg Res; 1990 Oct; 49(4):287-92. PubMed ID: 1699085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivity of monoclonal antibodies against lipopolysaccharides of gram-negative bacteria.
    de Jongh-Leuvenink J; Bouter AS; Marcelis JH; Schellekens J; Verhoef J
    Eur J Clin Microbiol; 1986 Apr; 5(2):148-51. PubMed ID: 2424754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The disaccharide L-alpha-D-heptose1-->7-L-alpha-D-heptose1-->of the inner core domain of Salmonella lipopolysaccharide is accessible to antibody and is the epitope of a broadly reactive monoclonal antibody.
    Nnalue NA; Lind SM; Lindberg AA
    J Immunol; 1992 Oct; 149(8):2722-8. PubMed ID: 1383323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-idiotypic immunization provides protection against lethal endotoxaemia in BALB/c mice.
    Cornelissen JJ; Maassen K; van Emst L; Weers PM; Harmsen M; Benaissa-Trouw BJ; Oosterlaken TA; Kraaijeveld CA; Verhoef J
    Immunology; 1993 Aug; 79(4):673-80. PubMed ID: 8406595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and binding specificity of a monoclonal antibody recognizing 3-deoxy-D-manno-2-octulosonic acid (Kdo) in lipopolysaccharides of Re chemotype.
    Pedron T; Girard R; Kosma P; Chaby R
    Hybridoma; 1992 Dec; 11(6):765-77. PubMed ID: 1294455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies specific for Escherichia coli J5 lipopolysaccharide: cross-reaction with other gram-negative bacterial species.
    Mutharia LM; Crockford G; Bogard WC; Hancock RE
    Infect Immun; 1984 Sep; 45(3):631-6. PubMed ID: 6381310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of cross-reactive antibodies to smooth gram-negative bacteria in antiserum to Escherichia coli J5.
    Baumgartner JD; O'Brien TX; Kirkland TN; Glauser MP; Ziegler EJ
    J Infect Dis; 1987 Jul; 156(1):136-43. PubMed ID: 2439613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme immunoassay for the quantitation of immunoglobulin M class antibodies to Salmonella minnesota R595 and Escherichia coli J5 lipopolysaccharides.
    Vanesian MA; Fung G; Bagdasarian A
    Diagn Microbiol Infect Dis; 1987 Jan; 6(1):11-25. PubMed ID: 3542358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of the binding specificity for five monoclonal antibodies recognizing 3-deoxy-D-manno-octulosonic acid in bacterial lipopolysaccharides.
    Lind SM; Kenne L; Lindberg AA
    J Immunol; 1991 Jun; 146(11):3864-70. PubMed ID: 2033255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activating and opsonic capacity of monoclonal antibodies raised against Escherichia coli O111 and its rough mutant J5.
    Vreede RW; Leuvenink J; Bouter AS; Brouwer EC; Marcelis JH; Verhoef J
    Eur J Clin Microbiol; 1986 Apr; 5(2):141-7. PubMed ID: 3522225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.